Yamanouchi Ireland plant using ABB’s IndustrialIT

Dublin, Ireland— Yamanouchi Ireland Co., Ltd., a subsidiary of Japan’s Yamanouchi Pharmaceuticals, recently announced that it will use ABB ‘s IndustrialITtechnology to upgrade its Dublin-based production facility.

‘The combination of technology, along with the need to meet the most stringent requirements of regulatory authorities, such as the U.S Food and Drug Administration; delivery schedules; and competitive pricing were decisive in Yamanouchi’s selection of ABB,’ says John Lehane, Yamanouchi`s technical services manager.

ABB’s scope includes delivering a process control system capable of being validated to meet FDA 21 CFR Part 11 regulations. The hardware/software platform includes ProduceITbatch recipe management; InformITInformation Manager plant historian; SattLine DCS, and ControlITlocal and S900 hazardous area remote I/O systems.

ABB’s contract services will include design, system engineering, testing, validation, and training.

Control Engineering Daily News DeskDave Harrold, senior editordharrold@reedbusiness.com

Do you have experience and expertise with the topics mentioned in this content? You should consider contributing to our WTWH Media editorial team and getting the recognition you and your company deserve. Click here to start this process.